European Registry Studying Outcomes After Transcatheter Repair or Replacement of the Tricuspid Valve

What this Trial Is About

Researchers are studying patients with tricuspid regurgitation, a heart valve condition linked to heart failure and high health risks. The study aims to observe clinical and survival outcomes after patients receive transcatheter tricuspid valve repair or replacement. This approach offers a new option for patients who face high risks with traditional surgery. Participants receive treatment using one of several transcatheter devices designed for tricuspid valve repair or replacement, including PASCAL, TriClip, TricValve, Evoque, or LuX-Valve. This is an observational registry collecting data in real-world settings to help improve patient selection and treatment quality for these procedures. During the study, participants will be monitored for up to five years to measure outcomes such as overall survival, technical success of the procedure, safety, heart failure markers, symptom improvement, heart function and size, valve function, and hospitalizations. This long-term follow-up will provide important information on how patients fare after these minimally invasive valve treatments.

European Registry of Transcatheter Repair for Tricuspid Regurgitation